HB 54 Delaware House · 152nd General Assembly (2023-2024)

AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE OF EPINEPHRINE AUTOINJECTORS.

Summary
Currently, all health insurance plans subject to requirements under Delaware law must include at least 1 formulation of epinephrine autoinjectors on the lowest tier of the carrier's drug formulary for individuals who are 18 years of age or younger. This Act expands this requirement to all covered individuals, regardless of age, by January 1, 2024. This Act also makes a technical correction to §§ 3571Y of Title 18 to add standard language about applicability, which is already in § 3370D of Title 18.
Bill status signed all 5 stages cleared
Introduction
Jan 2023
Committee Review
Apr 2023
House Passage
Mar 2023
Senate Passage
May 2023
Signed into Law
May 2023
Introduced Jan 19, 2023 Signed May 25, 2023
Floor votes · House Mar 14, 2023

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
7
Key actions
5
Committee
2
May 25, 2023
Signed into law
Signed by Governor
executive
May 9, 2023
Upper · Passed
Passed By Senate. Votes: 20 YES 1 NO
upper
Apr 5, 2023
Upper · Passed
Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 3 Favorable, 3 On Its Merits
upper
Mar 14, 2023
Introduced
Assigned to Banking, Business, Insurance & Technology Committee in Senate
upper
Mar 14, 2023
Lower · Passed
Passed By House. Votes: 39 YES 2 ABSENT
lower
Mar 7, 2023
Lower · Passed
Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 7 Favorable, 5 On Its Merits
lower
Jan 19, 2023
Introduced
Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
lower
18 primary · 0 co-sponsors

Sponsors